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Highlights 
• Myeloperoxidase-derived oxidants changed the product profile of 5-lipoxygenase. 
• The ratio of 5-HpETE to 6-trans-LTB4 increased with increasing HOCl and HOBr. 
• Epoxidation of 5-HpETE was more strongly affected than conversion of arachidonic acid. 
• 5-Lipoxygenase also produced 8- and 12-HpETE after incubation with HOCl and HOBr. 
• The whole myeloperoxidase system showed effects similar to those of HOCl and HOBr. 
Abstract 
Human 5-lipoxygenase (5-LOX) oxidizes arachidonic acid to 5S-hydroperoxy-6E,8Z,11Z,14Z-
eicosatetraenoic acid (5-HpETE) and leukotriene (LT) A4. In neutrophils, LTA4 is further 
converted to the potent chemoattractant LTB4. These cells also contain the heme enzyme 
myeloperoxidase (MPO), which produces several potent oxidants such as hypochlorous acid 
(HOCl), which are involved in pathogen defense and immune regulation. Here, we 
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addressed the question whether MPO-derived oxidants are able to affect the activity of 
5-LOX and the product profile of this enzyme. Human 5-LOX was incubated with increasing 
amounts of HOCl or HOBr. Afterward, arachidonic acid metabolites of 5-LOX were analyzed 
by reverse-phase high-performance liquid chromatography as well as by liquid 
chromatography-electrospray ionization-tandem mass spectrometry. The incubation of 
5-LOX with the MPO-derived oxidants significantly changed the product profile of 5-LOX. 
Thereby, HOCl and HOBr increased the ratio of 5-H(p)ETE to 6-trans-LTB4 in a 
concentration-dependent manner. At low oxidant concentrations, there was a strong 
decrease in the yield of 6-trans-LTB4, whereas 5-HpETE did not change or increased. 
Additionally, the formation of 8-HpETE and 12-HpETE by 5-LOX rose slightly with increasing 
HOCl and HOBr. Comparable results were obtained with the MPO-H2O2-Cl– system when 
glucose oxidase and glucose were applied as a source of H2O2. This was necessary because 
of a strong impairment of 5-LOX activity by H2O2. In summary, MPO-derived oxidants 
showed a considerable impact on 5-LOX, impairing the epoxidation of 5-HpETE, whereas 
the hydroperoxidation of arachidonic acid was unaffected. Apparently, this was caused by 
an oxidative modification of critical amino acid residues of 5-LOX. Further work is necessary 
to assess the specific type and position of oxidation in the substrate-binding cavity of 5-LOX 
and to specify whether this interaction between 5-LOX and MPO-derived oxidants also 
takes place in stimulated neutrophils.  
Keywords 
Eicosanoids, Arachidonic acid, HOCl, HOBr, Neutrophils, Free radicals  
Introduction 
During the innate immune response, polymorphonuclear leukocytes, also called 
neutrophils, are the first effector cells that will be recruited from the peripheral blood to 
inflammatory loci. These cells are equipped with an arsenal of protecting systems able to 
recognize, inactivate, and destroy foreign microorganisms. Enzymes and signaling systems 
will be sequentially activated in neutrophils during their interaction with the inflamed 
endothelium, during diapedesis and migration of these cells through the endothelial layer 
and adjacent space, as well as finally during recognition and phagocytosis of 
microorganisms [Kolaczkowska and Kubes 2013]. 
In this respect, 5-lipoxygenase (5-LOX), a non-heme-iron dioxygenase that uses arachidonic 
acid (AA) as substrate, is crucial for the chemotactic movement of neutrophils. This enzyme 
is also present in eosinophils, monocytes/macrophages, dendritic cells, and mast cells 
[Radmark et al. 2015]. Equimolar amounts of hydroperoxides can activate 5-LOX by 
oxidation of the inactive ferrous iron to the ferric form [Rouzer and Samuelsson 1986]. 
Afterward, the lipoxygenase reaction is started by stereoselective hydrogen abstraction at 
C7 of AA. Then, the resulting radical migrates to the C5 position, where it reacts with 
dioxygen forming a peroxyl radical. In a subsequent interaction with the ferrous form of 
5-LOX, a peroxyl anion is generated yielding 5S-hydroperoxy-6E,8Z,11Z,14Z-
eicosatetraenoic acid (5-HpETE) after protonation [Haeggstrom and Funk 2011]. Human 
5-LOX also possesses a secondary leukotriene A4 (LTA4) synthase activity [Rouzer et al. 
1986]. Thereby, a hydrogen at C10 of 5-HpETE is abstracted followed by a radical migration 
to the C6 position, rearrangement of double bonds, and formation of an epoxide moiety 
[Maas et al. 1982]. In neutrophils the unstable LTA4 is thereafter metabolized to 
leukotriene B4 (LTB4) by the action of LTA4 hydrolase [Newcomer and Gilbert 2010]. 
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Leukotriene B4, a potent autocrine chemoattractant to these cells, is released at the moving 
site of neutrophils where it acts on specific receptors and causes an actin contraction in the 
adjacent cell compartment [McDonald et al. 1994].  
The heme protein myeloperoxidase (MPO) is highly specific to neutrophils. It has also been 
found to a lesser extent in monocytes. Myeloperoxidase is present in the azurophilic 
granules that will fuse with phagocytosed bacteria. Constituents of azurophilic granules 
contribute to the inactivation and killing of microorganisms [Klebanoff et al. 2013]. 
Myeloperoxidase is known to be activated by hydrogen peroxide producing an arsenal of 
active oxidants including hypochlorous acid (HOCl) and hypobromous acid (HOBr) [Arnhold 
and Flemmig 2010]. Under physiological conditions especially HOCl is generated in 
neutrophils. Typical reaction partners of HOCl are thiols, thioethers, and amino groups 
[Hawkins et al. 2003]. Therefore, HOCl is principally able to oxidize amino acid residues of 
proteins, such as cysteine, methionine, tyrosine, tryptophan, and lysine residues [Pattison 
and Davies 2001]. Furthermore, various studies showed chemical modifications of certain 
proteins [Bouriche et al. 2007; Malle et al. 2006; Salavej et al. 2006]. 
Both enzymes, 5-LOX and MPO, get sequentially activated during migration of neutrophils 
to inflammatory loci. An increased Ca2+ level during neutrophil activation leads to 
translocation of cytosolic 5-LOX to the nuclear membrane and in consequence to the 
synthesis of LTB4, promoting chemotaxis of these cells [Radmark et al. 2015]. At the final 
destination of neutrophils, HOCl production via MPO is activated through stronger 
stimulation. Here, the question arises whether HOCl, a potent amino acid-oxidizing agent, 
could affect the activity or the product profile of 5-LOX. Previously, effects of a possible 
interaction of HOCl with AA-derived hydroperoxides were investigated [Zschaler and 
Arnhold 2014]. Here, the hydroperoxide moiety was not affected by HOCl, and 
chlorohydrins were formed instead. However, in the presence of a potential reaction 
partner of HOCl, such as the thioether group of methionine, the formation of chlorohydrins 
was disturbed [Zschaler and Arnhold 2014]. Thus, 5-LOX could be a better target site of 
HOCl. 
The aim of this study was to assess the effects of HOCl on the activity and product profile of 
5-LOX. Analysis was performed by reverse-phase high-performance liquid chromatography 
(RP-HPLC) as well as by liquid chromatography-electrospray ionization-tandem mass 
spectrometry (LC-ESI-MS/MS). Furthermore, hydrogen peroxide, also generated during 
neutrophil activation; hypobromous acid, the equivalent of HOCl in eosinophil granulocytes; 
and finally activated MPO were evaluated according to their impact on 5-LOX. We could 
demonstrate that HOCl, either present as a reagent or formed by the myeloperoxidase-
hydrogen peroxide-chloride system, and HOBr considerably affect the product profile of 
5-LOX, without, however, disturbing the lipoxygenase activity.  
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Material and methods 
Material 
Human 5-LOX was purchased from MyBioSource (supplier A, Catalog No. MBS537729, San 
Diego, CA, USA) or Cayman Chemical distributed by Biomol (supplier B, Catalog No. 
Cay60402, Hamburg, Germany). In both cases the recombinant enzyme was isolated from a 
baculovirus overexpression system in Sf21 cells and the S100 supernatant was used after 
centrifugation (100,000 g). A dialysis was performed against phosphate buffer (50 mM, pH 
7.4) to replace the Tris buffer of the commercial 5-LOX solution using a Slide-A-Lyzer dialysis 
cassette (3500 Da molecular mass cut-off, Thermo Scientific).  
The chemicals and further enzymes used were obtained from the following sources: human 
neutrophil myeloperoxidase from Planta (Vienna, Austria); glucose oxidase from bovine 
erythrocytes (G6137) from Sigma (Taufkirchen, Germany); HPLC standards 5-HpETE, 5S-
hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-HETE), 5S,12R-dihydroxy-6E,8E,10E,14Z-
eicosatetraenoic acid (5,12-DiHETE), 12S-hydroperoxy-5Z,8Z,10E,14Z-eicosatetraenoic acid 
(12-HpETE), 15S-hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic acid (15-HpETE), 13S-
hydroperoxy-9Z,11E-octadecadienoic acid (13-HpODE), and AA were from Cayman 
Chemical (distributed by Biomol); HPLC solvents were from Carl Roth (Karlsruhe, Germany); 
and all other chemicals were from Sigma. 
Working solutions of HOCl and H2O2 were prepared by dilution of the corresponding stock 
solutions. Their concentrations were determined spectrophotometrically using 
ε292 = 350 M–1 cm–1 at pH 12 in 1 N sodium hydroxide solution for –OCl [Morris 1966] and 
ε240 = 43.6 M-1 cm-1 for H2O2 [Beers and Sizer 1952]. The synthesis of HOBr was performed 
by the reaction of HOCl with bromide, whereby 40 mM NaBr was mixed with 20 mM HOCl 
in phosphate buffer (50 mM, pH 7.4). The concentration of –OBr was measured 
spectrophotometrically using ε329 = 332 M–1 cm–1 at pH 12 in 1 N sodium hydroxide solution 
[Kumar and Margerum 1987]. The solutions were essentially stable for 1 h at 4 °C and were 
used within this time. 
Incubation of human 5-LOX with various oxidants 
Dialyzed recombinant human 5-LOX (6 U) was incubated with various oxidants (HOCl, HOBr, 
or H2O2) at 20 °C in phosphate buffer (50 mM, pH 7.4) for 5 min (V = 80 µl) under shaking 
conditions (40 rpm). Afterward, 5-LOX activity assay was performed by addition of final 
100 µM AA, 5 µM 13-HpODE, 100 µM EDTA, 300 µM Ca2+ and 200 µM ATP and incubation 
for further 10 min (Vfinal = 100 µl). The reaction was terminated by the addition of 200 µl 
ice-cold acetonitrile and 3 µl acetic acid (100%) and the precipitate was separated by 
centrifugation (10 min, 4 °C, 10,000 g). The supernatants were stored at -80 °C and 
analyzed by RP-HPLC within 24 h.   
Incubation of human 5-LOX with the MPO-H2O2-Cl– system 
Dialyzed recombinant human 5-LOX (6 U) was incubated with 200 nM MPO, 140 mM NaCl, 
400 mU glucose oxidase, and 30-140 µM glucose at 20 °C in phosphate buffer (50 mM, pH 
7.4) for 15 min (V = 80 µl) under shaking conditions (40 rpm). Glucose oxidase and glucose 
were added to ensure a steady supply of low amounts of H2O2 and consequently activate 
MPO to produce HOCl. The synthesized HOCl was measured using a 3,3’,5,5’-
tetramethylbenzidine (TMB)-based assay [Dypbukt et al. 2005]. Afterward, the 5-LOX 
 
Zschaler et al.  Page 4/17 
 
 
Free Radical Biology and Medicine, provided by University Library Leipzig [2016] 
activity assay was performed (see Incubation of human 5-LOX with various oxidants). 
Finally, samples were stored at -80 °C and analyzed by RP-HPLC within 24 h.  
Analysis of 5-LOX products by RP-HPLC 
The samples were analyzed by RP-HPLC using a C18 column (Supelcosil LC-18-DB, 25 cm × 
4.6 mm i.d., 5 μm), with an isocratic eluent consisting of acetonitrile/H2O/acetic acid 
(60/40/0.2, v/v/v) with a flow rate of 1 ml/min. The eluate was monitored at 234 nm 
(quantification of conjugated dienes) and 270 nm (quantification of conjugated trienes). 
The HPLC consisted of a Shimadzu liquid chromatographic system equipped with a 
Shimadzu LC-10ATvp isocratic solvent delivery system, Shimadzu SPD-10Avp dual-
wavelength absorbance detector, Shimadzu CTO-10ASvp column oven (35 °C), and 
Rheodyne injector with 20 μl loop volume. The concentrations of the LOX products 
(5-H(p)ETE, 6-trans-LTB4, 12-HpETE) were quantified using a calibration curve (13-point 
calibration) of the appropriate synthetic standards. In the case of 8-HpETE no synthetic 
standard was available, therefore the 12-HpETE calibration curve was used instead. The 
identification of 8-HpETE was performed by MS/MS analysis after RP-HPLC separation. 
Therefore, a mixture of hydroperoxides of AA was synthesized using controlled 
α-tocopherol-inhibited autoxidation of AA [Peers and Coxon 1983]. Afterward, this mixture 
was separated by RP-HPLC as described above. Thereby 5-HETE showed a shoulder at a 
lower retention time. This peak was collected and analyzed by mass spectrometry. 
According to its fragmentation pattern this peak could be attributed to 8-HpETE [MacMillan 
and Murphy 1995]. 
Analysis of HOCl-modified 5-LOX products by LC-ESI-MS/MS 
Human 5-LOX (6 U) was incubated with HOCl as described under Incubation of human 5-
LOX with various oxidants. The reaction was terminated by dilution (1:500 and 1:5000) in 
phosphate buffer (50 mM, pH 7.4) and addition of 50 µl internal standard solution and 
400 µl precipitation reagent containing methanol:zinc sulfate 4:1 (v/v) to 200 µl of the 
corresponding sample. After 2 min vortexing the samples were centrifuged for 5 min at 
10,000 g and transferred in HPLC vials for storage at -80 °C. LC-ESI-MS/MS was performed 
according to Kortz et al. [Kortz et al. 2013]. In brief, 200 µl of the sample solution was 
injected onto a Strata-X extraction column (20 × 2 mm i.d., 25 µm, Phenomenex, 
Aschaffenburg, Germany) for online solid-phase extraction and chromatographically 
separated on a Kinetex C18 column (100 × 2.1 mm i.d., 2.6 µm, Phenomenex). A 5500 
QTrap mass spectrometer (AB Sciex, Darmstadt, Germany) in negative ionization mode was 
applied for MS/MS analysis with scheduled multiple-reaction monitoring (MRM) 
experiments. For detection of the 5-LOX metabolite 6-trans-LTB4 at the retention time of 
4.3 min the MRM m/z 335.2/194.9 was included in the experiment. Quantification of 
6-trans-LTB4 was performed using the LTB4 calibration curve (internal standard: LTB4-d4). 
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Results 
HOCl affects the product profile of human 5-LOX 
Arachidonic acid was converted by human 5-LOX into two major products, 5-HpETE and 
LTA4. 5-HpETE resulted from the dioxygen insertion at the C5 position of AA and can be 
reduced spontaneously or in vitro by a peroxidase-catalyzed reduction into 5-HETE due to 
the instability of the hydroperoxide group. Leukotriene A4 was rapidly nonenzymatically 
hydrolyzed into 6-trans-leukotriene B4 (6-trans-LTB4). Accordingly, chromatographic 
analysis of AA oxidation by 5-LOX revealed 5-HpETE (c = 28.7 µM), 5-HETE (c = 6.1 µM), and 
6-trans-LTB4 (c = 20.1 µM) (Figure 1 A and B, black line) as main products.  
Afterward, the influence of HOCl on the enzyme activity and product profile of 5-LOX was 
assessed. Thus, 5-LOX was incubated with increasing amounts of HOCl before the substrate 
mixture was added (Figure 1).  
 
Figure 1: Recombinant human 5-LOX (6 U, 46.5 U/mg, supplier A) was incubated with HOCl at 20 °C 
in phosphate buffer (50 mM, pH 7.4) for 5 min. Afterward, 100 μM AA, 5 μM 13-HpODE, 100 μM 
EDTA, 300 μM Ca2+, and 200 μM ATP were added and incubated for a further 10 min. The reaction 
was terminated by protein precipitation and the samples were analyzed by RP-HPLC at (A) 234 nm 
and (B) 270 nm. The concentrations of (C) 5-HpETE, 5-HETE, and 6-trans-LTB4 and 8-HpETE, 
12-HpETE, and 15-HpETE were calculated using a calibration curve of synthetic standards. pos/neg, 
positive/negative; two-tailed t test against positive control, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001; n = 3 
or 4. 
A significant increase in the 5-HpETE peak was observed at HOCl concentrations up to 
200 µM (Figure 1 A and C). Only at HOCl concentrations of 400 µM or higher, the yield of 
5-HpETE was lower than in the absence of HOCl. Interestingly, the peaks of 6-trans-LTB4 and 
5-HETE decreased over the whole HOCl concentration range (Figure 1 A, B, and C). 
Surprisingly, two further AA-derived products were detected after incubation of 5-LOX with 
HOCl, resulting from the oxygenation at C12 and C8 of AA (Figure 1 A, inset; Figure 1 C). 
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However, the maximal concentrations of 12-HpETE (cmax = 1.3 µM) and 8-HpETE (cmax = 2.3 
µM) were rather low.  
The AA solution was also measured as a negative control without the addition of 5-LOX 
(Figure 1 C, white bar). Here, low intense peaks for 15-HpETE and 5-HpETE were detected 
owing to nonspecific oxidation of the AA stock solution. Further nonspecific oxidation 
products such as 12/8-HpETE were not detected. A peroxide-free AA could not be used 
because of antioxidative additives interfering with HOCl. However, in the untreated 5-LOX 
samples 15-HpETE was not detected as a product (Figure 1 C, black bar). Possibly, low 
amounts of AA hydroperoxides were consumed during 5-LOX activation in addition to the 
applied 13-HpODE. After HOCl addition, low intense peaks were detected representing 
15-HpETE (cmax = 0.7 µM). It could not be evaluated whether this 15-HpETE was produced 
by 5-LOX or derived from the AA stock solution.  
The HOCl-induced changes in 5-LOX products revealed drastic differences between 5-HpETE 
on one hand and 5-HETE and 6-trans-LTB4 on the other (Figure 2 A). After application of 
150 µM HOCl a 1.76-fold increase in the 5-HpETE concentration took place, whereas a 1.27- 
and 1.86-fold decrease occurred for 5-HETE and 6-trans-LTB4, respectively. Apparently, low 
amounts of HOCl already blocked further conversions of 5-HpETE and caused, thus, a rise in 
5-HpETE production. 
 
Figure 2: HOCl-induced alterations in the product profile of human 5-LOX as described for Figure 1. 
(A) The HOCl-induced changes in the main products are related in percentage to the applied HOCl 
concentrations. Two-tailed t test against 5-HpETE, *p ≤ 0.05, **p ≤ 0.01. (B) The ratio of 5-H(p)ETE to 
6-trans-LTB4 was related to the applied HOCl concentration. n = 3 or 4. 
Taking into account that 5-H(p)ETE derived from the first oxygenation of AA by 5-LOX, and 
6-trans-LTB4 from the subsequent oxygenation, the ratio of 5-H(p)ETE to 6-trans-LTB4 
indicates the prevalence of the respective step (Figure 2 B). There was a linear increase in 
the 5-H(p)ETE to 6-trans-LTB4 ratio from 1.8:1 to 15.6:1 when 5-LOX was incubated with 
increasing HOCl concentrations. Hence, especially 5-HpETE was the dominating product of 
HOCl-modified 5-LOX, whereas the further conversion of 5-HpETE to LTA4 was strongly 
impaired. 
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Products of HOCl-modified 5-LOX analyzed by LC-ESI-MS/MS 
The product profile of 5-LOX after treatment with HOCl was further analyzed by LC-ESI-
MS/MS. This method enables a fast quantification of a broad spectrum of oxidized 
metabolites. In addition to the main products 5-H(p)ETE and 6-trans-LTB4, other further AA-
derived oxygenation products were detected, namely 5,6-DiHETE, 8-HETE, 12-HpETE, and 
5-oxo-ETE (Figure 3 A). However, their concentrations were rather low. 12-HpETE and 
8-HpETE were also measured using RP-HPLC (see HOCl affects the product profile of human 
5-LOX). For 8-HpETE no commercial standard was available, therefore it could not be 
measured with the applied LC-ESI-MS/MS. Nevertheless, the reduction product 8-HETE 
indicates the presence of 8-HpETE. Both 5,6-DiHETE and 5-oxo-ETE are further 
nonenzymatic hydrolysis products of LTA4 even though they emerged in lower amounts 
than the 5,12-DiHETE form (6-trans-LTB4) [Borgeat and Samuelsson 1979; Gravel et al. 
1993]. Both products were also detected using RP-HPLC; however, their concentrations 
were negligible compared to 6-trans-LTB4. 
The most significant HOCl-induced changes in the 5-LOX products arose for 6-trans-LTB4, 
5-HETE, and 5,6-DiHETE (Figure 3 A), where a strong decrease occurred. Also a decline was 
obvious for 5-oxo-ETE, albeit not to the same extent. These alterations are comparable to 
the previous experiment, also with regard to the further LTA4 hydrolysis products, 
5,6-DiHETE and 5-oxo-ETE.  
 
Figure 3: The incubation of 5-LOX (6 U, 162.9 U/mg, supplier A) with HOCl and the following activity 
assay were performed as described for Figure 1. The samples were analyzed by LC-ESI-MS/MS. (A) 
Concentrations of the main products were calculated using a calibration curve of synthetic 
standards. (B) The ratio of 5-H(p)ETE to 6-trans-LTB4 was related to the applied HOCl concentration. 
n = 3 or 4. 
The HOCl-induced effects on 5-HpETE correspond only partly to the results of the RP-HPLC 
analysis. The amount of 5-HpETE remained relatively stable after treatment of 5-LOX with 
HOCl. A comparable increase in the concentration at low HOCl did not occur. Also 12-HpETE 
showed only a modest HOCl-induced increase. However, here 12-HpETE belonged also to 
the untreated 5-LOX product profile. In the previous results 5-LOX produced 12-HpETE only 
after HOCl incubation (see HOCl affects the product profile of human 5-LOX). This slightly 
changed product profile can be explained with another enzyme charge used. Interestingly, 
for 8-HETE an initial rise in the concentration was detected, decreasing with higher HOCl 
amounts.  
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It has to be mentioned that there was a strong quantitative difference. Using the RP-HPLC a 
six times higher concentration of 5-HpETE was measured compared to the LC-ESI-MS/MS 
procedure. Also for 5-HETE and 6-trans-LTB4 lower amounts were detected with LC-ESI-
MS/MS. Apparently, the different precipitation procedure, necessary for LC-MS/MS 
measurement, affected the yield of 5-HpETE and diminished the effects of the HOCl-
induced increase. Nevertheless, when 5-LOX was incubated with HOCl in a concentration 
range from 10 to 250 µM HOCl the ratio of 5-H(p)ETE to 6-trans-LTB4 showed a comparable 
strong increase, from 1.9:1 to 15.7:1 (Figure 3 B). In the previous experiments, HOCl was 
tested in a concentration range between 50 and 500 µM leading to an increase in the ratio 
of 5-H(p)ETE to 6-trans-LTB4 from 1.8:1 to 15.6:1 (Figure 1). These differences in HOCl 
concentration can be attributed to the different enzyme charges used, affecting the 
required HOCl amount for a comparable effect. 
Inactivation of human 5-LOX by H2O2 
The product profile of HOCl-treated 5-LOX was extensively changed, especially concerning 
the ratio of 5-HpETE to LTA4. However, it is not clear if a slight inactivation of the enzyme 
happens after HOCl incubation. Therefore, the effect of HOCl on the product profile of 
5-LOX was compared to H2O2 as a further reactive oxygen species. For this purpose, 5-LOX 
was incubated with H2O2 under conditions comparable to those of HOCl. Afterward, the 
substrate mixture was added and the product profile of 5-LOX was assessed by RP-HPLC 
(Figure 4).  
 
Figure 4: Recombinant 5-LOX (6 U, 34.4 U/mg, supplier B) was incubated with H2O2 at 20 °C in 
phosphate buffer (50 mM, pH 7.4) for 5 min. Afterward, an activity assay of 5-LOX and 
chromatographic quantification of the product profile was performed and (A) H2O2-induced changes 
in percentage of the product profile of human 5-LOX were calculated. (B) The ratio of 5-H(p)ETE to 
6-trans-LTB4 was related to the applied H2O2 concentration. n = 3 or 4. 
With increasing amounts of H2O2 both 5-HpETE and 5-HETE, as well as 6-trans-LTB4, 
displayed a substantial decrease especially in the range from 5 µM to 20 µM H2O2 (Figure 
4 A). For 6-trans-LTB4 a considerable decline of 77% was observed but also concentrations 
of 5-HETE and 5-HpETE were markedly reduced by 39 and 49%, respectively. Higher H2O2 
concentrations up to 80 µM resulted in only slightly further changes. Interestingly, 
12-HpETE and 8-HpETE, detected as clear signals with the enzyme preparation used at 
3.2 and 2.9 µM, respectively, completely diminished up to 20 µM H2O2. This highlights 
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clearly the different actions of HOCl and H2O2 in relation to 5-LOX, where both these 
oxidation products increased in their concentration after HOCl treatment. The H2O2-
induced changes in the ratio of 5-H(p)ETE to 6-trans-LTB4 were also determined (Figure 
4 B). It became evident that also for H2O2-treated 5-LOX this ratio increased from 5.5:1 to 
17.4:1. This could be explained by the faster decrease in 6-trans-LTB4 compared to 
5-H(p)ETE. However, for HOCl a linear correlation between HOCl and 5-H(p)ETE to 6-trans-
LTB4 occurred, whereas H2O2 induced an exponential rise. This was apparently caused by 
the stronger effect in the range between 5 and 20 µM H2O2.  
HOBr affects the product profile of human 5-LOX 
A further prominent hypohalous acid produced from peroxidases is hypobromous acid. 
HOBr was also assessed according to its effects on the product profile of 5-LOX. Here, HOBr 
was incubated in the range from 10 to 250 µM with 5-LOX before the enzyme activity was 
determined (Figure 5).  
 
Figure 5: Recombinant 5-LOX (6 U, 34.4 U/mg, supplier B) was incubated with HOBr at 20 °C in 
phosphate buffer (50 mM, pH 7.4) for 5 min. Afterward, an activity assay of 5-LOX and 
chromatographic quantification of the product profile were performed and HOBr-induced changes in 
percentage of the product profile of human 5-LOX were calculated for (A) 5-H(p)ETE and 6-trans-LTB4 
and (B) 8-HpETE and 12-HpETE. (C) The ratio of 5-H(p)ETE to 6-trans-LTB4 was related to the applied 
HOBr concentration. Two-tailed t test against control, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001; n = 4. 
The lowest HOBr concentration induced an increase in all metabolites. However, higher 
amounts of HOBr led to a significant reduction in 6-trans-LTB4 and 5-HETE, whereas for 
5-HpETE a significantly higher concentration was still present (Figure 5 A). For example, 125 
µM HOBr induced a 1.17-fold increase in 5-HpETE and a decrease of 49 and 62% for 5-HETE 
and 6-trans-LTB4, respectively. Interestingly, a distinctive HOBr-induced augmentation was 
observed for 8-HpETE and 12-HpETE. Here, 125 µM HOBr caused a 1.67- and 2.16-fold 
increase in 8-HpETE and 12-HpETE, respectively (Figure 5 B). Furthermore, the ratio of 
 
Zschaler et al.  Page 10/17 
 
 
Free Radical Biology and Medicine, provided by University Library Leipzig [2016] 
5-H(p)ETE to 6-trans-LTB4 was determined (Figure 5 C) showing a linear dependence on the 
applied HOBr concentration. Unmodified 5-LOX had a ratio of 5-H(p)ETE to 6-trans-LTB4 of 
4.4:1, growing up to 10.1:1 after addition of 250 µM HOBr. This was comparable to the 
HOCl-induced 5-LOX effects. However, for unmodified 5-LOX (see HOCl affects the product 
profile of human 5-LOX) a lower ratio of 5-H(p)ETE to 6-trans-LTB4 was determined, which 
can be attributed to the different enzyme charges used.  
Interaction of activated MPO and human 5-LOX 
The heme-containing protein MPO produces HOCl in neutrophil granulocytes after 
activation by hydrogen peroxide. The MPO-H2O2-Cl– system was now applied to modify the 
product profile of human 5-LOX. As demonstrated above H2O2 easily inactivates 5-LOX (see 
Inactivation of human 5-LOX by H2O2). Therefore, a simple addition of H2O2 was not possible 
for MPO activation in the presence of 5-LOX. The glucose oxidase/glucose (GOD/Glu) 
system was used instead, to ensure a steady supply of low amounts of H2O2. Different 
glucose concentrations were added to glucose oxidase to achieve different degrees of MPO 
activation and subsequently variable HOCl concentrations. The efficiency of the MPO-
GOD/Glu-Cl– system was tested by HOCl quantification using a TMB-based assay. Thereby, 
half of the applied glucose was converted into HOCl (data not shown). Afterward, 5-LOX 
was incubated with MPO and the GOD/Glu system (Figure 6). As controls Cl– was omitted as 
MPO substrate or the GOD/Glu system alone was added to 5-LOX. Here, a strong decrease 
in the concentrations of all metabolites was observed. For example, addition of 100 µM 
glucose to the 5-LOX/MPO/GOD samples devoid of Cl– resulted in a 3.3- and 10.9-fold 
decrease for 5-HpETE and 6-trans-LTB4, respectively. This was comparable to the H2O2 
effect seen earlier (Inactivation of human 5-LOX by H2O2). Also 12-HpETE and 8-HpETE 
produced from unaffected 5-LOX completely disappeared in these controls. The addition of 
Cl– to 5-LOX, MPO, and the GOD/Glu system also resulted in a reduction in 5-HETE and 
6-trans-LTB4. Also the amount of 5-HpETE was attenuated; however, only to a minor degree 
compared to 6-trans-LTB4. Here, 100 µM glucose led to a 1.2- and 3.1-fold decrease for 
5-HpETE and 6-trans-LTB4, respectively. The small changes in the 5-HpETE concentration 
might be due to the H2O2-driven impairment of 5-LOX activity. This could superimpose the 
HOCl-induced 5-HpETE increase. Interestingly, the amount of 12-HpETE and 8-HpETE was 
unaffected in the 5-LOX, MPO, Cl–, and GOD/Glu samples, clearly distinguishing them from 
the negative controls in which 5-LOX was influenced by the H2O2-generating system.  
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Figure 6: Recombinant human 5-LOX (6 U, 162.9 U/mg, supplier A) was incubated with 200 nM 
MPO, 400 mU glucose oxidase, and various amounts of glucose at 20 °C in phosphate buffer (50 mM, 
pH 7.4) for 15 min (V = 80 µl). Afterward an activity assay of 5-LOX and chromatographic 
quantification of the product profile were performed. The concentrations of (A) 5-HpETE, 5-HETE, 
and 6-trans-LTB4 and (B) 8-HpETE, 12-HpETE, and 15-HpETE were calculated using a calibration curve 
of synthetic standards. (C) HOCl-induced changes in percentage of the product profile of human 5-
LOX after incubation with activated MPO (MPO + Cl– + GOD) and further negative controls with MPO 
+ GOD in the absence of Cl– and sole addition of the GOD/Glu system to 5-LOX. pos/neg, 
positive/negative; GOD, glucose oxidase; Glu, glucose, n = 3. 
As shown in the previous experiments the ratio of 5-H(p)ETE to 6-trans-LTB4 was 
determined (Figure 7). An exponential increase in this ratio occurred for both 
5-LOX/MPO/GOD samples devoid of Cl– (from 3.7:1 to 14.0:1) and 5-LOX/GOD samples 
(from 3.7:1 to 22.7:1) depending on the added glucose concentration, which is comparable 
to the inactivation of 5-LOX with H2O2 (see Inactivation of human 5-LOX by H2O2). The 
addition of Cl– to 5-LOX, MPO, and the GOD/Glu system led in turn to a slower rise in the 
ratio of 5-H(p)ETE to 6-trans-LTB4 (from 3.7:1 to 14.0:1). 
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Figure 7: Recombinant human 5-LOX (6 U) was incubated with MPO, glucose oxidase, and various 
amounts of glucose (see Figure 6). Afterward, an activity assay of 5-LOX and chromatographic 
quantification of the product profile were performed. The ratio of 5-H(p)ETE to 6-trans-LTB4 was 
related to the applied glucose concentration. GOD, glucose oxidase; Glu, glucose. 
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Discussion 
5-Lipoxgenase is known to catalyze two successive reactions in the formation of potent 
bioactive metabolites derived from AA. First, this enzyme oxidizes AA into 5-HpETE and 
converts in a second step this hydroperoxide into LTA4. Whereas the formation of 5-HpETE 
and 5-HETE, the reduced form of 5-HpETE, could be directly verified with our methods, the 
formation of the unstable LTA4 was evaluated assessing its nonenzymatic hydrolysis 
product 6-trans-LTB4. 
The incubation of 5-LOX with the MPO-derived oxidants HOCl and HOBr significantly 
changed the product profile of 5-LOX in a concentration-dependent manner. There was a 
linear increase in the ratio of 5-H(p)ETE to 6-trans-LTB4 with increasing concentrations of 
HOCl and HOBr. At low oxidant concentrations, there was a strong decrease in the yield of 
6-trans-LTB4, whereas 5-HpETE did not change or increased. 5-HpETE was decreased only at 
higher concentrations for HOCl and HOBr. Incubation of 5-LOX with H2O2 diminished all 
peaks of interest, with the highest impact on 6-trans-LTB4. Therefore, also for the 5-H(p)ETE 
to 6-trans-LTB4 ratio an increase was obvious with increasing H2O2 concentration, but not in 
a linear manner. Thus, whereas small MPO-related oxidants mostly disturb the conversion 
of 5-HpETE into LTA4 by 5-LOX, H2O2 impaired the whole 5-LOX activity. A reaction of HOCl 
and HOBr with the AA-derived products itself can be ruled out. Previous studies showed 
that the double bonds are a target site for HOCl, but only in the absence of further reaction 
partners such as the thioether group of methionine [Zschaler and Arnhold 2014]. 
We applied two 5-LOX preparations from different suppliers. These preparations differed in 
their 5-H(p)ETE to 6-trans-LTB4 ratio of the unperturbed sample. The initial ratios were 1.8 
to 3.7 and 4.4 to 5.5 for supplier A and B, respectively (see Results). We can only speculate 
about the reasons for these differences. It is clear that the addition of HOCl or H2O2 to 
5-LOX leads to an increased 5-H(p)ETE to 6-trans-LTB4 ratio. Whether the increased ratio of 
the untreated 5-LOX is related to a preoxidized enzyme preparation could not been 
examined. 
The 5-H(p)ETE to 6-trans-LTB4 ratio increased also after incubation of 5-LOX with the MPO-
H2O2-Cl– system. Owing to the high impact of H2O2 on 5-LOX, glucose oxidase/glucose was 
applied as a source of H2O2. This reduced considerably the actual concentrations of 
hydrogen peroxide over a bolus addition. According to the results for H2O2, the product 
ratio of 5-H(p)ETE and 6-trans-LTB4 increased also in a nonlinear manner using glucose 
oxidase/glucose alone or with MPO in the absence of chloride. However, the complete 
MPO system had a much lower impact on the product profile of 5-LOX.  
A second observation was the increased formation of 8-HpETE and 12-HpETE in 5-LOX 
samples incubated with HOCl, HOBr, and the MPO-H2O2-Cl– system, which could not be 
detected after incubation of 5-LOX with H2O2. Instead, H2O2 or the GOD/Glu system 
disturbed the primarily produced 8-HpETE and 12-HpETE formation. In addition to 5-HpETE 
these hydroperoxides are well known to be produced by 5-LOX with a lower yield [Walther 
et al. 2009], which could be verified by our results. We further observed an increased 
formation of these products with increasing HOCl and HOBr concentrations.  
In two different studies human 5-LOX was converted into a 15-lipoxygenating enzyme by 
mutational introduction of a space-filling amino acid, reducing the volume of the substrate 
cavity, or by mimicking the Ser663 phosphorylation site [Gilbert et al. 2012; Schwarz et al. 
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2001]. We measured a slightly increasing peak for 15-HpETE in HOCl-influenced 5-LOX 
samples compared to the untreated sample. Even though 15-HpETE was already obvious in 
the AA stock solution, apparently owing to autoxidation, in untreated 5-LOX samples no 
15-HpETE was present. Probably, 15-HpETE reacts during the enzymatic activity assay with 
ferrous 5-LOX during lipoxygenase activation, comparable to 13-HpODE [Riendeau et al. 
1989; Schilstra et al. 1992]. Now, the slightly increased HOCl-dependent 15-HpETE peak 
could be due to an effect of HOCl on the general 5-LOX activity, leading to lower enzyme 
activation and thus a reduced consumption of 15-HpETE introduced via the AA stock 
solution. However, low concentrations of HOCl did not disturb the 5-HpETE-producing 
activity of 5-LOX, assuming that 5-LOX activation is comparable. Therefore, it is more 
possible that in addition to the changed oxidation specificity, leading to 12-HpETE and 
8-HpETE, 15-HpETE is also produced by 5-LOX. 
The influence of HOCl on the product profile of 5-LOX was also analyzed with LC-ESI-
MS/MS, a sophisticated technique to measure a high number of oxidized metabolites in a 
relatively short time. In principal, a comparable HOCl effect was detected, leading to a 
linear increase in the 5-H(p)ETE to 6-trans-LTB4 ratio. However, the quantitative results 
could not be compared. Here, for 5-HpETE and 6-trans-LTB4, a 6.1- and 3.8-fold lower 
concentration was measured with LC-ESI-MS/MS compared to RP-HPLC, respectively, 
whereas for 5-HETE only a 1.2-fold lower concentration was obvious. This could be 
reasoned by the application of different precipitation procedures, the lack of the 
appropriate internal standard for 5-HpETE quantification, or the instability of 5-HpETE 
during electrospray ionization diminishing the effects of the HOCl-induced increase in 
5-HpETE. 
In addition to 6-trans-LTB4 and 5,6-DiHETE as nonenzymatic hydrolysis products of LTA4 
[Gravel et al. 1993], 5-oxo-ETE was also measured in the LOX samples using the LC-ESI-
MS/MS technique. 5-Oxo-ETE could be nonspecifically formed from the decomposition of 
5-HpETE during the preparation or after injection onto the column, resulting in 5-oxo-
6E,8Z,11Z,14Z-eicosatetraenoic acid. This phenomenon was reported for the injection of 
12-HpETE or 15-HpETE onto an HPLC column without prior reduction [Fruteau de Laclos and 
Borgeat 1988]. However, the measured product might also be 5-oxo-7E,9E,11Z,14Z-
eicosatetraenoic acid, a further nonenzymatic hydrolysis product of LTA4 [Gravel et al. 
1993], differing only in the position of the double bonds. Gravel et al. described an MS/MS 
fragment with m/z 203 Da for 5-oxo-7E,9E,11Z,14Z-eicosatetraenoic acid [Gravel et al. 
1993], which is also used for the applied LC-ESI-MS/MS analysis of 5-oxo-ETE. Thus, the 
triene structure (5-oxo-7E,9E,11Z,14Z-eicosatetraenoic acid) is thought to have the same 
retention time as the stereoisomer 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid in the LC-ESI-
MS/MS analysis. 
5-LOX possesses two functions during leukotriene biosynthesis, hydroperoxidation and 
epoxidation, certainly differing in their catalytic mechanism [Rouzer et al. 1986]. The 
hydroperoxidation is initiated by pro-S hydrogen abstraction at C7 of AA, whereas 
epoxidation proceeds after abstraction of the pro-R hydrogen at C10, suggesting a different 
position of the substrate relative to the ferric active center [Haeggstrom and Funk 2011]. 
Furthermore, the resulting radical reacts only in the hydroperoxidation step with molecular 
dioxygen to a peroxyl radical species, which is subsequently reduced by ferrous iron. In 
contrast, during epoxidation the hydroperoxide group is homolytically cleaved by ferrous 
iron, yielding a hydroxide radical for epoxidation. Recently detailed kinetic investigations of 
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these two processes were performed, indicating that both the rate of substrate capture and 
the rate of product release are less efficient for epoxidation than for hydroperoxidation 
[Smyrniotis et al. 2014]. Furthermore, it was assumed that for 5-LOX it is more efficient to 
retain the 5-HpETE in its active site for sequential epoxidation, rather than binding free 
5-HpETE [Smyrniotis et al. 2014]. Therefore, the impact of the MPO-derived oxidants on the 
product profile of 5-LOX could be related to the oxidation of critical amino acid residues in 
the substrate binding cavity disturbing mostly the less efficient epoxidation of 5-HpETE, 
whereas the hydroperoxidation of AA is unaffected. Further, 5-HpETE is more compact and 
more hydrophilic than AA. Thus, slight changes in the conformation of the substrate cavity 
due to amino acid oxidation could result in an impaired radical formation at C10 or the 
disturbance of a further step during epoxidation.  
In addition, the crystal structure of human 5-LOX revealed a unique Phe, Tyr-cork feature 
blocking the possible entrance to the active site [Gilbert et al. 2011]. Modification of these 
two amino acids could result in a changed entrance mechanism, affecting the uptake of AA 
and 5-HpETE in a different way. However, at the moment, we can only speculate as to 
which fine mechanisms take place. To verify these differences, it is highly necessary to 
combine our measurements with proteomic analysis for any oxidant-mediated 
modifications in the protein structure of 5-LOX.  
Hydrogen peroxide affected both reactions catalyzed by 5-LOX, hydroperoxidation and 
epoxidation, with a stronger impact on the formation of LTA4. As explained above, this 
might be related to the less efficient epoxidation reaction. However, H2O2 clearly 
diminished the whole 5-LOX activity, assuming a direct impact on the active center of the 
5-LOX. The inactivation mechanism could involve a reaction between H2O2 and ferrous iron 
[Percival et al. 1992]. Furthermore, the iron ligand histidines are potential target sites for 
metal-catalyzed oxidation reactions [Dean et al. 1989].   
Changes in the product profile of 5-LOX were investigated in in vitro enzyme preparations. 
It is highly necessary to extend these measurements to neutrophil granulocytes containing 
both 5-LOX and MPO. Alternatively, eosinophils are also an interesting target as they 
contain two lipoxygenases, namely 5-LOX and 15-LOX, and eosinophil peroxidase producing 
HOBr. The activation of 5-LOX in granulocytes is an early event in inflammation and 
immune response. In neutrophils, LTB4 is an important chemotactic agent, necessary for the 
directed movement of these cells to inflammatory loci. Enhanced oxidant formation by 
MPO is mostly related to phagocytosis of microorganisms and their digestion in 
phagosomes. Apparently, MPO-derived oxidants play a certain role in terminating signals 
for the formation of LTB4. 
Declaration of Interest 
The authors have no conflicts of interest to declare. The authors alone are responsible for 
the content and writing of the paper. 
Acknowledgement 
The authors gratefully acknowledge the financial support provided by the Sächsische 
Aufbaubank through funding from the European Regional Development Fund (SAB Project 
No. 100116526) and the German Federal Ministry of Education and Research (BMBF 
1315883). 
 
Zschaler et al.  Page 16/17 
 
 
Free Radical Biology and Medicine, provided by University Library Leipzig [2016] 
References 
Arnhold J, Flemmig J (2010) Human myeloperoxidase in innate and acquired immunity. Arch Biochem 
Biophys 500, 92-106. 
Beers RF, Sizer I (1952) A spectrophotometric method for measuring the breakdown of hydrogen 
peroxide by catalase. J Biol Chem 195, 133-40. 
Borgeat P, Samuelsson B (1979) Metabolism of arachidonic acid in polymorphonuclear leukocytes. 
Structural analysis of novel hydroxylated compounds. J Biol Chem 254, 7865-9. 
Bouriche H, Salavei P, Lessig J, Arnhold J (2007) Differential effects of flavonols on inactivation of 
alpha1-antitrypsin induced by hypohalous acids and the myeloperoxidase-hydrogen peroxide-halide 
system. Arch Biochem Biophys 459, 137-42. 
Dean RT, Wolff SP, McElligott MA (1989) Histidine and proline are important sites of free radical 
damage to proteins. Free Radic Res Commun 7, 97-103. 
Dypbukt JM, Bishop C, Brooks WM, Thong B, Eriksson H, Kettle AJ (2005) A sensitive and selective 
assay for chloramine production by myeloperoxidase. Free Radic Biol Med 39, 1468-77. 
Fruteau de Laclos B, Borgeat P (1988) Conditions for the formation of the oxo derivatives of 
arachidonic acid from platelet 12-lipoxygenase and soybean 15-lipoxygenase. Biochim Biophys Acta 
958, 424-33. 
Gilbert NC, Bartlett SG, Waight MT, Neau DB, Boeglin WE, Brash AR, Newcomer ME (2011) The 
structure of human 5-lipoxygenase. Science 331, 217-9. 
Gilbert NC, Rui Z, Neau DB, Waight MT, Bartlett SG, Boeglin WE, Brash AR, Newcomer ME (2012) 
Conversion of human 5-lipoxygenase to a 15-lipoxygenase by a point mutation to mimic 
phosphorylation at Serine-663. FASEB J 26, 3222-9. 
Gravel J, Falgueyret JP, Yergey J, Trimble L, Riendeau D (1993) Identification of 5-keto-
(7E,9E,11Z,14Z)-eicosatetraenoic acid as a novel nonenzymatic rearrangement product of 
leukotriene A4. Arch Biochem Biophys 306, 469-75. 
Haeggstrom JZ, Funk CD (2011) Lipoxygenase and leukotriene pathways: biochemistry, biology, and 
roles in disease. Chem Rev 111, 5866-98. 
Hawkins CL, Pattison DI, Davies MJ (2003) Hypochlorite-induced oxidation of amino acids, peptides 
and proteins. Amino Acids 25, 259-74. 
Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM (2013) Myeloperoxidase: a front-line 
defender against phagocytosed microorganisms. J Leukoc Biol 93, 185-98. 
Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. 
Nat Rev Immunol 13, 159-75. 
Kortz L, Dorow J, Becker S, Thiery J, Ceglarek U (2013) Fast liquid chromatography-quadrupole linear 
ion trap-mass spectrometry analysis of polyunsaturated fatty acids and eicosanoids in human 
plasma. J Chromatogr B Analyt Technol Biomed Life Sci 927, 209-13. 
Kumar K, Margerum DW (1987) Kinetics and mechanism of general-acid-assisted oxidation of 
bromide by hypochlorite and hypochlorous acid. Inorg Chem 26, 2706-11. 
Maas RL, Ingram CD, Taber DF, Oates JA, Brash AR (1982) Stereospecific removal of the DR hydrogen 
atom at the 10-carbon of arachidonic acid in the biosynthesis of leukotriene A4 by human 
leukocytes. J Biol Chem 257, 13515-9. 
 
Zschaler et al.  Page 17/17 
 
 
Free Radical Biology and Medicine, provided by University Library Leipzig [2016] 
MacMillan DK, Murphy RC (1995) Analysis of lipid hydroperoxides and long-chain conjugated keto 
acids by negative ion electrospray mass spectrometry. J Am Soc Mass Spectrom 6, 1190-201. 
Malle E, Marsche G, Panzenboeck U, Sattler W (2006) Myeloperoxidase-mediated oxidation of high-
density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins. Arch 
Biochem Biophys 445, 245-55. 
McDonald PP, McColl SR, Braquet P, Borgeat P (1994) Autocrine enhancement of leukotriene 
synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils. Br J 
Pharmacol 111, 852-60. 
Morris JC (1966) Acid ionization constant of HOCl from 5 to 35 degrees. J Phys Chem 70, 3798-805. 
Newcomer ME, Gilbert NC (2010) Location, location, location: compartmentalization of early events 
in leukotriene biosynthesis. J Biol Chem 285, 25109-14. 
Pattison DI, Davies MJ (2001) Absolute rate constants for the reaction of hypochlorous acid with 
protein side chains and peptide bonds. Chem Res Toxicol 14, 1453-64. 
Peers KE, Coxon DT (1983) Controlled synthesis of monohydroperoxides by alpha-tocopherol 
inhibited autoxidation of poly-unsaturated lipids. Chem Phys Lipids 32, 49-56. 
Percival MD, Denis D, Riendeau D, Gresser MJ (1992) Investigation of the mechanism of non-
turnover-dependent inactivation of purified human 5-lipoxygenase. Inactivation by H2O2 and 
inhibition by metal ions. Eur J Biochem 210, 109-17. 
Radmark O, Werz O, Steinhilber D, Samuelsson B (2015) 5-Lipoxygenase, a key enzyme for 
leukotriene biosynthesis in health and disease. Biochim Biophys Acta 1851, 331-9. 
Riendeau D, Falgueyret JP, Nathaniel DJ, Rokach J, Ueda N, Yamamoto S (1989) Sensitivity of 
immunoaffinity-purified porcine 5-lipoxygenase to inhibitors and activating lipid hydroperoxides. 
Biochem Pharmacol 38, 2313-21. 
Rouzer CA, Matsumoto T, Samuelsson B (1986) Single protein from human leukocytes possesses 5-
lipoxygenase and leukotriene A4 synthase activities. Proc Natl Acad Sci USA 83, 857-61. 
Rouzer CA, Samuelsson B (1986) The importance of hydroperoxide activation for the detection and 
assay of mammalian 5-lipoxygenase. FEBS Lett 204, 293-6. 
Salavej P, Spalteholz H, Arnhold J (2006) Modification of amino acid residues in human serum 
albumin by myeloperoxidase. Free Radic Biol Med 40, 516-25. 
Schilstra MJ, Veldink GA, Verhagen J, Vliegenthart JF (1992) Effect of lipid hydroperoxide on 
lipoxygenase kinetics. Biochemistry 31, 7692-9. 
Schwarz K, Walther M, Anton M, Gerth C, Feussner I, Kuhn H (2001) Structural basis for lipoxygenase 
specificity. Conversion of the human leukocyte 5-lipoxygenase to a 15-lipoxygenating enzyme 
species by site-directed mutagenesis. J Biol Chem 276, 773-9. 
Smyrniotis CJ, Barbour SR, Xia Z, Hixon MS, Holman TR (2014) ATP allosterically activates the human 
5-lipoxygenase molecular mechanism of arachidonic acid and 5(S)-hydroperoxy-6(E),8(Z),11(Z),14(Z)-
eicosatetraenoic acid. Biochemistry 53, 4407-19. 
Walther M, Roffeis J, Jansen C, Anton M, Ivanov I, Kuhn H (2009) Structural basis for pH-dependent 
alterations of reaction specificity of vertebrate lipoxygenase isoforms. Biochim Biophys Acta 1791, 
827-35. 
Zschaler J, Arnhold J (2014) The hydroperoxide moiety of aliphatic lipid hydroperoxides is not 
affected by hypochlorous acid. Chem Phys Lipids 184, 42-51. 
